Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Startup’s Technology Could Improve Cancer Drug Development

By R&D Editors | November 4, 2014

David Nolte, president of Animated Dynamics Inc. said pharmaceutical companies screen millions of compounds annually to find new drug candidates. In traditional lead testing, which occurs at a later stage in the process, tens of thousands of compounds are screened in Petri dishes.

“The biology happening in Petri dishes during lead testing is not the biology that goes on inside a tissue. There are differences in how cells respond to drugs in a three-dimensional environment, which means the results that occur in Petri dishes may not be the same as the results that occur in the body,” said Nolte, who also is a professor in Purdue’s Department of Physics and Astronomy. “The advantage our technology provides is that it can help with lead selection of compounds in a biologically relevant context.”

Nolte and John Turek, the company’s executive vice president and chief financial officer, created technology that uses holography and lasers to study a cell’s phenotype, or the observable traits that result from how cells in tissues interact with their environment. The technology was highlighted in a letter of the peer-reviewed Journal of Biomedical Optics.

Turek, who also is a professor in Purdue’s Department of Basic Medical Sciences, said the technology makes digital holograms of tissues. The holographic technique allows researchers to see all the way through a tissue, not just the surface.

“We use spectroscopy to measure the time-dependent changes in the hologram,” he said. “It breaks down the changes into different frequencies, and we can tell how a cell’s membranes, mitochondria, nucleus and even cell division respond to drugs. We measure the frequency of the light fluctuations as a function of time after a drug is applied.”

Nolte said Animated Dynamics’ technology can be used to assess the efficacy of drug combinations, called regimens, on personal cancers.

“No two cancers are alike. Therefore, every patient needs his or her own selected therapy to get the best results,” he said. “Our technology can measure a cancer tumor’s response to cancer therapy, such as metabolism and cell division. This can tell how well the drug is working for the patient and can aid in predicting side effects.”

The technology has been licensed to Animated Dynamics through the Purdue Office of Technology Commercialization. More than 20 startups based on Purdue intellectual property were launched in the 2014 fiscal year.The company is based in the Purdue Research Park of West Lafayette.

Animated Dynamics received a six-month SBIR Phase I grant worth $150,000 from the National Science Foundation to develop a microscope attachment to help scientists study the motion and dynamics inside a cell. The attachment will turn a standard microscope into a biodynamic microscope that studies a cell’s phenotype, or the observable traits that result from how cells interact with their environment.

Date: November 4, 2014

Source: Purdue University

Related Articles Read More >

For the first time, scientists grow beating human-pig hearts for 21 days
Open-source Boltz-2 can speed binding-affinity predictions 1,000-fold
Thermo Fisher’s new Orbitrap Excedion Pro targets complex biotherapeutics for drug development
FDA’s new ‘Elsa’ AI set to expedite clinical protocol reviews
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE